Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

336.74 +0.74 (+0.22%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2 3 4 5 6 7 8 9

...

60 61 Next >

10 Health Care Stocks Whale Activity In Today's Session ↗

November 05, 2025

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

November 05, 2025

Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns

November 05, 2025

Seattle, WA – November 5, 2025 – In a monumental leap for biotechnology and artificial intelligence, Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design...

Via TokenRing AI

Topics Artificial Intelligence Intellectual Property

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Price Over Earnings Overview: Amgen ↗

October 17, 2025

Via Benzinga

AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance

November 05, 2025

Biotech company Amgen (NASDAQ:AMGN) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 12.4% year on year to $9.56 billion. The company’s full-year revenue guidance of...

Via StockStory

These S&P500 stocks that are showing activity before the opening bell on Wednesday. ↗

November 05, 2025

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.

Via Chartmill

Amgen (NASDAQ:AMGN) Delivers Strong Q3 Numbers

November 04, 2025

Biotech company Amgen (NASDAQ:AMGN) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 12.4% year on year to $9.56 billion. The company’s full-year revenue guidance of $36.2 billion at...

Via StockStory

Amgen Crushes Third-Quarter Expectations On The Back Of Two Blockbusters ↗

November 04, 2025

The biotech giant also raised its sales and adjusted earnings outlook for the year.

Via Investor's Business Daily

Topics Earnings

Palantir Weighs On Wall Street, Bitcoin Slumps 5%: What's Moving Markets Tuesday? ↗

November 04, 2025

Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, offering a convenient excuse to take profits after strong year-to-date...

Via Benzinga

Amgen Earnings: What To Look For From AMGN

November 02, 2025

Biotech company Amgen (NASDAQ:AMGN) will be reporting earnings this Tuesday after market close. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

You Won't Believe What Elon Musk Just Said About Quantum Computing (Spoiler Alert: It's Good News) ↗

November 02, 2025

Elon Musk had some encouraging thoughts following Alphabet's latest quantum breakthrough.

Via The Motley Fool

Topics Artificial Intelligence

Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout

October 31, 2025

Thousand Oaks, CA – October 31, 2025 – Amgen (NASDAQ: AMGN), a leading biotechnology giant, has declared a quarterly dividend of $2.38 per share for the fourth quarter of 2025. This significant...

Via MarketMinute

Topics Intellectual Property

AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs

October 31, 2025

San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of...

Via TokenRing AI

Topics Artificial Intelligence Supply Chain

AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future

October 31, 2025

The pharmaceutical industry is in the midst of a profound and rapid transformation, driven by the pervasive integration of Artificial Intelligence (AI). What was once a futuristic concept is, by late...

Via TokenRing AI

Topics Animal Testing Artificial Intelligence Economy

How Royalty Pharma Prints Cash Without Biotech's Biggest Risks ↗

October 31, 2025

Via MarketBeat

Marjorie Taylor Greene Buys Netflix Stock After Downbeat Q3 Earnings, Expands Big Tech Bet ↗

October 31, 2025

MTG "buys the dip" on Netflix (NFLX) stock after a bad Q3 report. See all 14 of her new purchases, including MSFT and AMZN.

Via Benzinga

Marjorie Taylor Greene Buys 6 Stocks: Buffett, Health Care — And This Magnificent 7 Stock ↗

October 29, 2025

Marjorie Taylor Greene discloses buying more stocks in October. Here's a look at what she added to her portfolio.

Via Benzinga

S&P 500 Healthcare Sector Navigates Mixed Market Waters on October 29, 2025

October 29, 2025

On October 29, 2025, the broader market exhibited a decidedly mixed performance, reflecting a prevailing sense of uncertainty among investors. Against this backdrop of fluctuating sentiment, the S&P...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

What Does the Market Think About Amgen Inc? ↗

October 27, 2025

Via Benzinga

2 Value Stocks on Our Watchlist and 1 Facing Headwinds

October 27, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Via StockStory

Topics Artificial Intelligence

Biogen's Immunology Pipeline Has Long-Term Potential: Analyst ↗

October 24, 2025

Biogen gains exclusive rights to Vanqua's oral C5aR1 antagonist, boosting its immunology pipeline with potential across multiple immune diseases.

Via Benzinga

1 Top Dividend Growth Stock to Buy Right Now ↗

October 24, 2025

Its shares might not remain undervalued for that much longer.

Via The Motley Fool

Topics Economy Government Intellectual Property

Halper Sadeh LLC Encourages Amgen Inc. Shareholders to Contact the Firm to Discuss Their Rights

October 22, 2025

From Halper Sadeh LLC

Via Business Wire

Market Minute: Dow Soars, Apple Hits Record High as 20-Day Government Shutdown Fuels Gold Rally

October 20, 2025

The U.S. financial markets opened the week with a robust performance on October 20, 2025, as the Dow Jones Industrial Average (DJIA) extended its gains, and tech giant Apple Inc. (NASDAQ: AAPL) reached...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

2 Reasons to Like AMGN and 1 to Stay Skeptical

October 20, 2025

Although Amgen (currently trading at $299.86 per share) has gained 9.6% over the last six months, it has trailed the S&P 500’s 29.3% return during that period. This might have investors contemplating...

Via StockStory

Topics Stocks

United Therapeutics Forges Ahead with Share Repurchases, Not Dividends, Following July 2025 Volume Surge

October 17, 2025

In a financial landscape often fixated on consistent dividend payouts, United Therapeutics Corporation (NASDAQ: UTHR) stands out with a distinct capital allocation strategy. Contrary to market...

Via MarketMinute

Topics Retirement

Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Drugs? ↗

October 17, 2025

Trump's promise to cut cost of Novo Nordisk A/S drug Ozempic from $1,300 to $150 shakes GLP-1 gold rush, with potential impact on Eli Lilly and Pfizer.

Via Benzinga

Topics Government

Marjorie Taylor Greene, Cathie Wood Snap Up The Same 13 Stocks — Here's the Unlikely Portfolio Crossover ↗

October 16, 2025

A look at the stock owned by both Ark Funds and Congresswoman Marjorie Taylor Greene.

Via Benzinga

Small-Cap Biotech Climb Bio's Lead Drug Candidate Has Larger Long-Term Opportunity ↗

October 16, 2025

William Blair assigns Climb Bio an Outperform rating, projecting peak sales of $1.9 billion and long-term growth for its therapy pipeline.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

60 61 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.